Skip to Main Content

Paper Details

SMARCB1 loss induces druggable cyclin D1 deficiency via upregulation of MIR17HG in atypical teratoid rhabdoid tumors.
J Pathol
10
2020
ATRT, Atypical teratoid rhabdoid tumor, CCND1, CDK4, CDK4/6, MIR17HG, SMARCB1, SNF, SWI, atypical, atypical teratoid rhabdoid tumors, cyclin D1, cyclin D1 deficiency, cyclin D1 protein, miRNAs, microRNA, microRNA (miRNA) cluster, p16, palbociclib, patient, patients, pediatric malignancy of the central neural system, rhabdoid tumor, rhabdoid tumor family, tumors
Author NameAffiliation
Sriram VennetiUniversity of Michigan Medical School ann arbor
Daniel MartinezChildren's Hospital of Philadelphia Research Institute
Daniel MartinezChildren's Hospital of Philadelphia Research Institute
Alexander R JudkinsChildren's Hospital Los Angeles, Keck School of Medicine of University of Southern California
William D FoulkesMcGill University
William D FoulkesLady Davis Institute, Jewish General Hospital, McGill University
William D FoulkesMcGill University Health Centre
William D FoulkesMcGill University
William D FoulkesLady Davis Institute, Jewish General Hospital, McGill University
William D FoulkesMcGill University Health Centre
  • 1 - 10

Datasets

Release 1.2